$8B Bayer cancer settlement offer may delay August trial

Bayer is offering to pay up to $8 billion to settle thousands of lawsuits claiming its weedkiller causes cancer, according to Bloomberg.

Advertisement

The Germany-based pharmaceutical company is facing more than 18,000 lawsuits linked to its Roundup herbicide, acquired in 2018 when it bought chemical giant Monsanto.

While Bayer has proposed $6 billion to $8 billion to resolve the lawsuits, plaintiffs’ lawyers want more than $10 billion, according to the report. 

Negotiations have advanced to the point that lawyers for the plaintiffs and Bayer have asked two judges in St. Louis to postpone a trial that is set to begin this month. 

Read the full report here.

More articles on pharmacy:
2020 election brewing ‘perfect storm’ for drug-pricing reform, analyst says
Colombia fines Pfizer $25K for drug price inflation
Jefferson Healthcare opens retail specialty pharmacy

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.